Ghost Tree Capital, LLC Hedge Fund

CIK: 0001595851 · Show all filings

Period: Q1 2016 (← Previous) (Next →)

Filing Date: May 16, 2016

Total Value: $177M (100.0% shares, 0.0% debt)

Holdings (51)

XBI SPDR SERIES TRUST 6.2%
Value $11.04M Shares 220,000 Est. Cost Unrealized
ACAD ACADIA PHARMACEUTICALS INC 5.5%
Value $9.786M Shares 350,000 Est. Cost $35.23 Unrealized -38.0%
CELGENE CORP 5.1%
Value $9.028M Shares 90,202 Est. Cost $100.09 Unrealized
EW EDWARDS LIFESCIENCES CORP 5.0%
Value $8.821M Shares 100,000 Est. Cost Unrealized
BSX BOSTON SCIENTIFIC CORP 4.8%
Value $8.465M Shares 450,000 Est. Cost $17.57 Unrealized 0.0%
IWM ISHARES TR 4.7%
Value $8.297M Shares 75,000 Est. Cost Unrealized
HORIZON PHARMA PLC 4.0%
Value $7.042M Shares 425,000 Est. Cost $16.57 Unrealized
PACB PACIFIC BIOSCIENCES CALIF IN 3.4%
Value $5.95M Shares 700,000 Est. Cost $8.97 Unrealized +9.6%
ABBV ABBVIE INC 3.2%
Value $5.712M Shares 100,000 Est. Cost Unrealized
AGIO AGIOS PHARMACEUTICALS INC 3.2%
Value $5.684M Shares 140,000 Est. Cost $42.75 Unrealized 0.0%
ALEXION PHARMACEUTICALS INC 3.2%
Value $5.569M Shares 40,000 Est. Cost $139.22 Unrealized
TEVA TEVA PHARMACEUTICAL INDS LTD 3.0%
Value $5.351M Shares 100,000 Est. Cost Unrealized
MIRATI THERAPEUTICS INC 3.0%
Value $5.35M Shares 250,000 Est. Cost $31.60 Unrealized
SAGE THERAPEUTICS INC 2.9%
Value $5.13M Shares 160,000 Est. Cost $56.65 Unrealized
SPECTRANETICS CORP 2.9%
Value $5.082M Shares 350,000 Est. Cost $13.18 Unrealized
OPHTHOTECH CORP 2.9%
Value $5.072M Shares 120,000 Est. Cost $42.27 Unrealized
IHF ISHARES TR 2.7%
Value $4.818M Shares 39,500 Est. Cost $121.97 Unrealized
NEVRO CORP 2.4%
Value $4.22M Shares 75,000 Est. Cost $67.51 Unrealized
NANOSTRING TECHNOLOGIES INC 1.9%
Value $3.425M Shares 225,000 Est. Cost $13.25 Unrealized
NUVASIVE INC 1.9%
Value $3.406M Shares 70,000 Est. Cost $46.62 Unrealized
IART INTEGRA LIFESCIENCES HLDGS C 1.9%
Value $3.368M Shares 50,000 Est. Cost $31.26 Unrealized -0.4%
BMRN BIOMARIN PHARMACEUTICAL INC 1.9%
Value $3.299M Shares 40,000 Est. Cost $81.36 Unrealized 0.0%
IHI ISHARES TR 1.7%
Value $3.062M Shares 25,000 Est. Cost $122.48 Unrealized
RMD RESMED INC 1.6%
Value $2.891M Shares 50,000 Est. Cost $50.48 Unrealized 0.0%
VALEANT PHARMACEUTICALS INTL 1.5%
Value $2.63M Shares 100,000 Est. Cost Unrealized
DBV TECHNOLOGIES S A 1.5%
Value $2.583M Shares 45,000 Est. Cost $66.42 Unrealized
ACAD ACADIA PHARMACEUTICALS INC 1.2%
Value $2.097M Shares 75,000 Est. Cost $35.23 Unrealized -38.0%
WRIGHT MED GROUP N V 1.2%
Value $2.075M Shares 125,000 Est. Cost $24.18 Unrealized
PORTOLA PHARMACEUTICALS INC 1.2%
Value $2.04M Shares 100,000 Est. Cost $48.90 Unrealized
ST JUDE MED INC 1.1%
Value $2.008M Shares 36,500 Est. Cost $55.01 Unrealized
VRTX VERTEX PHARMACEUTICALS INC 1.1%
Value $2.007M Shares 25,253 Est. Cost $90.45 Unrealized 0.0%
ENTELLUS MED INC 1.1%
Value $2.001M Shares 110,000 Est. Cost $16.86 Unrealized
MDT MEDTRONIC PLC 1.1%
Value $1.993M Shares 26,578 Est. Cost $58.89 Unrealized 0.0%
ACHILLION PHARMACEUTICALS IN 1.1%
Value $1.93M Shares 250,000 Est. Cost $8.85 Unrealized
VCYT VERACYTE INC 1.0%
Value $1.845M Shares 341,708 Est. Cost $8.42 Unrealized -29.8%
CYNAPSUS THERAPEUTICS INC 1.0%
Value $1.803M Shares 151,535 Est. Cost $16.29 Unrealized
GENMARK DIAGNOSTICS INC 0.9%
Value $1.581M Shares 300,000 Est. Cost $9.06 Unrealized
IHE ISHARES TR 0.8%
Value $1.342M Shares 9,800 Est. Cost $136.94 Unrealized
TANDEM DIABETES CARE INC 0.7%
Value $1.307M Shares 150,000 Est. Cost $11.81 Unrealized
LION BIOTECHNOLOGIES INC 0.7%
Value $1.27M Shares 250,000 Est. Cost $5.08 Unrealized
ALCOBRA LTD 0.6%
Value $1.137M Shares 300,000 Est. Cost $5.68 Unrealized
PORTOLA PHARMACEUTICALS INC 0.5%
Value $816K Shares 40,000 Est. Cost $48.90 Unrealized
CHIASMA INC 0.4%
Value $687K Shares 75,000 Est. Cost $9.16 Unrealized
ENDO INTL PLC 0.4%
Value $678K Shares 24,100 Est. Cost $28.13 Unrealized
VITAE PHARMACEUTICALS INC 0.4%
Value $671K Shares 101,188 Est. Cost $12.29 Unrealized
AKARI THERAPEUTICS PLC 0.4%
Value $653K Shares 46,622 Est. Cost $18.60 Unrealized
HRTX HERON THERAPEUTICS INC 0.3%
Value $475K Shares 25,000 Est. Cost $19.73 Unrealized 0.0%
ADAPY ADAPTIMMUNE THERAPEUTICS PLC 0.2%
Value $407K Shares 50,000 Est. Cost $12.06 Unrealized
CLOVIS ONCOLOGY INC 0.2%
Value $355K Shares 18,500 Est. Cost $19.19 Unrealized
STRONGBRIDGE BIOPHARMA PLC 0.2%
Value $332K Shares 72,726 Est. Cost $7.60 Unrealized
OCERA THERAPEUTICS INC 0.1%
Value $132K Shares 45,000 Est. Cost $10.04 Unrealized